Skip to main navigation Skip to search Skip to main content

Design of EFGR kinase domain inhibitors for the potential treatment of lung and other cancers

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - Dec 13 2019

Disciplines

  • Chemistry

Cite this